The Global Antibiotic Research & Development Partnership (GARDP) accelerates the development and access of treatments for drug-resistant infections. Together with private, public and non-profit partners, GARDP works to preserve the power of antibiotics for generations to come.
GARDP seeks to discover and develop antibiotics for the most difficult-to-treat infections and make them accessible to people everywhere.
GARDP is based in Switzerland and has over 50 employees and contractors with rich experience from the private, non-profit, academic and public sectors. They work closely with the GARDP global network, including GARDP North America, representation in Australia, the DNDi-GARDP Southern Africa joint office, the Drugs for Neglected Diseases initiative, and associated DNDi regional offices in Brazil, India, Japan, Kenya and Malaysia.